By Ana Cláudia Santos (Merck Brazil), Chris Foti (Gilead Sciences), Flavia Firmino (Pfizer), John Campbell (GlaxoSmithKline), Steven Baertschi (Baertschi Consulting)
Published in: European Pharmaceutical Review
Published on: December 22, 2021
A team of American scientists report on some recent developments in the realm of pharmaceutical stress testing, or forced degradation, practices relating to solid dosage forms, bringing some valuable clarity for drug developers.
